{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:06:45Z","timestamp":1791302805706,"version":"4.1.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,1,8]],"date-time":"2013-01-08T00:00:00Z","timestamp":1357603200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s12016-012-8347-6","type":"journal-article","created":{"date-parts":[[2013,1,7]],"date-time":"2013-01-07T04:56:07Z","timestamp":1357534567000},"page":"180-192","source":"Crossref","is-referenced-by-count":111,"title":["Use of Mesenchymal Stem Cells (MSC) in Chronic Inflammatory Fistulizing and Fibrotic Diseases: a Comprehensive Review"],"prefix":"10.1007","volume":"45","author":[{"given":"Jan","family":"Voswinkel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Francois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Benderitter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert-Claude","family":"Gorin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Mohty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Fouillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Chapel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,8]]},"reference":[{"key":"8347_CR1","doi-asserted-by":"crossref","first-page":"R1304","DOI":"10.1186\/ar1827","volume":"7","author":"F Djouad","year":"2005","unstructured":"Djouad F, Bony C, Haupl T et al (2005) Transcriptional profiles discriminate bone marrow-derived and synovium-derived mesenchymal stem cells. Arthritis Res Ther 7:R1304\u2013R1315","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"8347_CR2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/1529-0131(200101)44:1<85::AID-ANR12>3.0.CO;2-6","volume":"44","author":"C Bari De","year":"2001","unstructured":"De Bari C, Dell\u2019Accio F, Luyten FP (2001) Human periosteum-derived cells maintain phenotypic stability and chondrogenic potential throughout expansion regardless of donor age. Arthritis Rheum 44(1):85\u201395","journal-title":"Arthritis Rheum"},{"key":"8347_CR3","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.yexcr.2007.12.022","volume":"314","author":"D Noel","year":"2008","unstructured":"Noel D, Caton D, Roche S et al (2008) Cell specific differences between human adipose-derived and mesenchymal-stromal cells despite similar differentiation potentials. Exp Cell Res 314:1575\u20131584","journal-title":"Exp Cell Res"},{"key":"8347_CR4","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S1063-4584(03)00167-5","volume":"11","author":"S Fickert","year":"2003","unstructured":"Fickert S, Fiedler J, Brenner RE (2003) Identification, quantification and isolation of mesenchymal progenitor cells from osteoarthritic synovium by fluorescence automated cell sorting. Osteoarthr Cartil 11:790\u2013800","journal-title":"Osteoarthr Cartil"},{"key":"8347_CR5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1365-3083.2003.01176.x","volume":"57","author":"K Blanc Le","year":"2003","unstructured":"Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringden O (2003) Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 57:11\u201320","journal-title":"Scand J Immunol"},{"issue":"3","key":"8347_CR6","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/01.TP.0000045055.63901.A9","volume":"75","author":"WT Tse","year":"2003","unstructured":"Tse WT, Pendleton JD, Beyer WM, Egalka MC, Guinan EC (2003) Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75(3):389\u2013397","journal-title":"Transplantation"},{"key":"8347_CR7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11373-004-8183-7","volume":"12","author":"E Klyushnenkova","year":"2005","unstructured":"Klyushnenkova E, Mosca JD, Zernetkina V et al (2005) T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. J Biomed Sci 12:47\u201357","journal-title":"J Biomed Sci"},{"key":"8347_CR8","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1097\/01.TP.0000082540.43730.80","volume":"76","author":"I Rasmusson","year":"2003","unstructured":"Rasmusson I, Ringden O, Sundberg B, Le Blanc K (2003) Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 76:1208\u20131213","journal-title":"Transplantation"},{"key":"8347_CR9","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/j.yexcr.2006.03.019","volume":"312","author":"I Rasmusson","year":"2006","unstructured":"Rasmusson I (2006) Immune modulation by mesenchymal stem cells. Exp Cell Res 312:2169\u20132179","journal-title":"Exp Cell Res"},{"key":"8347_CR10","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.immuni.2009.03.015","volume":"30","author":"K Tokoyoda","year":"2009","unstructured":"Tokoyoda K, Zehentmeier S, Hegazy AN et al (2009) Professional memory CD4+ T lymphocytes preferentially reside and rest in the bone marrow. Immunity 30:721\u2013730","journal-title":"Immunity"},{"key":"8347_CR11","doi-asserted-by":"crossref","first-page":"e1886","DOI":"10.1371\/journal.pone.0001886","volume":"3","author":"L Chen","year":"2008","unstructured":"Chen L, Tredget EE, Wu PY, Wu Y (2008) Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One 3:e1886","journal-title":"PLoS One"},{"key":"8347_CR12","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","volume":"105","author":"S Aggarwal","year":"2005","unstructured":"Aggarwal S, Pittenger MF (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105:1815\u20131822","journal-title":"Blood"},{"key":"8347_CR13","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nm.1905","volume":"15","author":"K Nemeth","year":"2009","unstructured":"Nemeth K, Leelahavanichkul A, Yuen PS et al (2009) Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 15:42\u201349","journal-title":"Nat Med"},{"key":"8347_CR14","doi-asserted-by":"crossref","first-page":"6576","DOI":"10.1182\/blood-2009-02-203943","volume":"113","author":"GM Spaggiari","year":"2009","unstructured":"Spaggiari GM, Abdelrazik H, Becchetti F, Moretta L (2009) MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. Blood 113:6576\u20136583","journal-title":"Blood"},{"key":"8347_CR15","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1634\/stemcells.2006-0548","volume":"25","author":"F Djouad","year":"2007","unstructured":"Djouad F, Charbonnier LM, Bouffi C et al (2007) Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism. Stem Cells 25:2025\u20132032","journal-title":"Stem Cells"},{"key":"8347_CR16","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1182\/blood-2004-02-0586","volume":"105","author":"XX Jiang","year":"2005","unstructured":"Jiang XX, Zhang Y, Liu B et al (2005) Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 105:4120\u20134126","journal-title":"Blood"},{"key":"8347_CR17","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/stem.118","volume":"27","author":"G Ren","year":"2009","unstructured":"Ren G, Su J, Zhang L et al (2009) Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression. Stem Cells 27:1954\u20131962","journal-title":"Stem Cells"},{"key":"8347_CR18","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1182\/blood-2006-02-002246","volume":"109","author":"K Sato","year":"2007","unstructured":"Sato K, Ozaki K, Oh I et al (2007) Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood 109:228\u2013234","journal-title":"Blood"},{"key":"8347_CR19","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.tp.0000267918.07906.08","volume":"84","author":"A Nasef","year":"2007","unstructured":"Nasef A, Mathieu N, Chapel A et al (2007) Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G. Transplantation 84:231\u2013237","journal-title":"Transplantation"},{"key":"8347_CR20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1751-553X.2007.00997.x","volume":"31","author":"A Nasef","year":"2009","unstructured":"Nasef A, Zhang YZ, Mazurier C et al (2009) Selected Stro-1-enriched bone marrow stromal cells display a major suppressive effect on lymphocyte proliferation. Int J Lab Hematol 31:9\u201319","journal-title":"Int J Lab Hematol"},{"key":"8347_CR21","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3324\/haematol.11240","volume":"92","author":"C Prevosto","year":"2007","unstructured":"Prevosto C, Zancolli M, Canevali P, Zocchi MR, Poggi A (2007) Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction. Haematologica 92:881\u2013888","journal-title":"Haematologica"},{"key":"8347_CR22","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1634\/stemcells.2007-0790","volume":"26","author":"B Parekkadan","year":"2008","unstructured":"Parekkadan B, Tilles AW, Yarmush ML (2008) Bone marrow-derived mesenchymal stem cells ameliorate autoimmune enteropathy independently of regulatory T cells. Stem Cells 26:1913\u20131919","journal-title":"Stem Cells"},{"key":"8347_CR23","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood-2005-04-1496","volume":"106","author":"E Zappia","year":"2005","unstructured":"Zappia E, Casazza S, Pedemonte E et al (2005) Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106:1755\u20131761","journal-title":"Blood"},{"key":"8347_CR24","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.mehy.2007.08.010","volume":"70","author":"H Zhou","year":"2008","unstructured":"Zhou H, Jin Z, Liu J, Yu S, Cui Q, Yi D (2008) Mesenchymal stem cells might be used to induce tolerance in heart transplantation. Med Hypotheses 70:785\u2013787","journal-title":"Med Hypotheses"},{"key":"8347_CR25","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.4049\/jimmunol.179.3.1595","volume":"179","author":"MA Haniffa","year":"2007","unstructured":"Haniffa MA, Wang XN, Holtick U et al (2007) Adult human fibroblasts are potent immunoregulatory cells and functionally equivalent to mesenchymal stem cells. J Immunol 179:1595\u20131604","journal-title":"J Immunol"},{"key":"8347_CR26","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1182\/blood-2005-07-2657","volume":"107","author":"A Corcione","year":"2006","unstructured":"Corcione A, Benvenuto F, Ferretti E et al (2006) Human mesenchymal stem cells modulate B-cell functions. Blood 107:367\u2013372","journal-title":"Blood"},{"key":"8347_CR27","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/art.24405","volume":"60","author":"MA Gonzalez","year":"2009","unstructured":"Gonzalez MA, Gonzalez-Rey E, Rico L, Buscher D, Delgado M (2009) Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. Arthritis Rheum 60:1006\u20131019","journal-title":"Arthritis Rheum"},{"key":"8347_CR28","first-page":"248","volume":"3","author":"A Malgieri","year":"2010","unstructured":"Malgieri A, Kantzari E, Patrizi MP, Gambardella S (2010) Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art. Int J Clin Exp Med 3:248\u201326","journal-title":"Int J Clin Exp Med"},{"key":"8347_CR29","doi-asserted-by":"crossref","unstructured":"Voswinkel, J., and Chapel, A. (2012). Mesenchymal stem cells and rheumatism: state of the art. Z Rheumatol.","DOI":"10.1007\/s00393-011-0950-z"},{"key":"8347_CR30","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3727\/000000006783981503","volume":"15","author":"KJ Beggs","year":"2006","unstructured":"Beggs KJ, Lyubimov A, Borneman JN et al (2006) Immunologic consequences of multiple, high-dose administration of allogeneic mesenchymal stem cells to baboons. Cell Transplant 15:711\u2013721","journal-title":"Cell Transplant"},{"key":"8347_CR31","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2796.2007.01844.x","volume":"262","author":"K Blanc Le","year":"2007","unstructured":"Le Blanc K, Ringden O (2007) Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med 262:509\u2013525","journal-title":"J Intern Med"},{"key":"8347_CR32","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1158\/0008-5472.CAN-04-4194","volume":"65","author":"D Rubio","year":"2005","unstructured":"Rubio D, Garcia-Castro J, Martin MC et al (2005) Spontaneous human adult stem cell transformation. Cancer Res 65:3035\u20133039","journal-title":"Cancer Res"},{"key":"8347_CR33","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1182\/blood-2009-05-219907","volume":"115","author":"K Tarte","year":"2010","unstructured":"Tarte K, Gaillard J, Lataillade JJ et al (2010) Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation. Blood 115:1549\u20131553","journal-title":"Blood"},{"key":"8347_CR34","doi-asserted-by":"crossref","first-page":"9142","DOI":"10.1158\/0008-5472.CAN-06-4690","volume":"67","author":"ME Bernardo","year":"2007","unstructured":"Bernardo ME, Zaffaroni N, Novara F et al (2007) Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res 67:9142\u20139149","journal-title":"Cancer Res"},{"key":"8347_CR35","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1136\/ard.2009.123463","volume":"69","author":"J Liang","year":"2010","unstructured":"Liang J, Zhang H, Hua B et al (2010) Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study. Ann Rheum Dis 69:1423\u20131429","journal-title":"Ann Rheum Dis"},{"key":"8347_CR36","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1002\/art.27548","volume":"62","author":"L Sun","year":"2010","unstructured":"Sun L, Wang D, Liang J et al (2010) Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis Rheum 62:2467\u20132475","journal-title":"Arthritis Rheum"},{"key":"8347_CR37","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1517\/14712590902956615","volume":"9","author":"GW Dryden","year":"2009","unstructured":"Dryden GW (2009) Overview of stem cell therapy for Crohn\u2019s disease. Expert Opin Biol Ther 9:841\u2013847","journal-title":"Expert Opin Biol Ther"},{"key":"8347_CR38","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1517\/14712590903048909","volume":"9","author":"GW Dryden Jr","year":"2009","unstructured":"Dryden GW Jr (2009) Overview of biologic therapy for Crohn\u2019s disease. Expert Opin Biol Ther 9:967\u2013974","journal-title":"Expert Opin Biol Ther"},{"key":"8347_CR39","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1097\/01.TP.0000062540.29757.E9","volume":"75","author":"M Ditschkowski","year":"2003","unstructured":"Ditschkowski M, Einsele H, Schwerdtfeger R et al (2003) Improvement of inflammatory bowel disease after allogeneic stem-cell transplantation. Transplantation 75:1745\u20131747","journal-title":"Transplantation"},{"key":"8347_CR40","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1007\/s10350-005-0052-6","volume":"48","author":"D Garcia-Olmo","year":"2005","unstructured":"Garcia-Olmo D, Garcia-Arranz M, Herreros D, Pascual I, Peiro C, Rodriguez-Montes JA (2005) A phase I clinical trial of the treatment of Crohn\u2019s fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum 48:1416\u20131423","journal-title":"Dis Colon Rectum"},{"key":"8347_CR41","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/DCR.0b013e3181973487","volume":"52","author":"D Garcia-Olmo","year":"2009","unstructured":"Garcia-Olmo D, Herreros D, Pascual I et al (2009) Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Dis Colon Rectum 52:79\u201386","journal-title":"Dis Colon Rectum"},{"key":"8347_CR42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00384-008-0559-0","volume":"24","author":"D Garcia-Olmo","year":"2009","unstructured":"Garcia-Olmo D, Herreros D, Pascual M et al (2009) Treatment of enterocutaneous fistula in Crohn\u2019s disease with adipose-derived stem cells: a comparison of protocols with and without cell expansion. Int J Colorectal Dis 24:27\u201330","journal-title":"Int J Colorectal Dis"},{"key":"8347_CR43","doi-asserted-by":"crossref","first-page":"961758","DOI":"10.1155\/2010\/961758","volume":"2010","author":"D Garcia-Olmo","year":"2010","unstructured":"Garcia-Olmo D, Herreros D, De-La-Quintana P et al (2010) Adipose-derived stem cells in Crohn\u2019s rectovaginal fistula. Case Report Med 2010:961758","journal-title":"Case Report Med"},{"key":"8347_CR44","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1136\/gut.2010.215152","volume":"59","author":"M Duijvestein","year":"2010","unstructured":"Duijvestein M, Vos AC, Roelofs H et al (2010) Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn\u2019s disease: results of a phase I study. Gut 59:1662\u20131669","journal-title":"Gut"},{"key":"8347_CR45","first-page":"38","volume":"82","author":"LB Lazebnik","year":"2010","unstructured":"Lazebnik LB, Konopliannikov AG, Kniazev OV et al (2010) Use of allogeneic mesenchymal stem cells in the treatment of intestinal inflammatory diseases. Ter Arkh 82:38\u201343","journal-title":"Ter Arkh"},{"key":"8347_CR46","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/gut.2010.214841","volume":"60","author":"R Ciccocioppo","year":"2011","unstructured":"Ciccocioppo R, Bernardo ME, Sgarella A et al (2011) Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulizing Crohn\u2019s disease. Gut 60:788\u2013798","journal-title":"Gut"},{"key":"8347_CR47","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/art.22698","volume":"56","author":"P Cipriani","year":"2007","unstructured":"Cipriani P, Guiducci S, Miniati I et al (2007) Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis. Arthritis Rheum 56:1994\u20132004","journal-title":"Arthritis Rheum"},{"key":"8347_CR48","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/ard.2007.071233","volume":"67","author":"J Larghero","year":"2008","unstructured":"Larghero J, Farge D, Braccini A et al (2008) Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis. Ann Rheum Dis 67:443\u2013449","journal-title":"Ann Rheum Dis"},{"key":"8347_CR49","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1002\/art.30431","volume":"63","author":"G Keyszer","year":"2011","unstructured":"Keyszer G, Christopeit M, Fick S et al (2011) Treatment of severe progressive systemic sclerosis with transplantation of mesenchymal stromal cells from allogeneic related donors: report of five cases. Arthritis Rheum 63:2540\u20132542","journal-title":"Arthritis Rheum"},{"key":"8347_CR50","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1182\/blood-2006-12-041889","volume":"109","author":"HJ Deeg","year":"2007","unstructured":"Deeg HJ (2007) How I treat refractory acute GVHD. Blood 109:4119\u20134126","journal-title":"Blood"},{"key":"8347_CR51","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/01.tp.0000214462.63943.14","volume":"81","author":"O Ringden","year":"2006","unstructured":"Ringden O, Uzunel M, Rasmusson I et al (2006) Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 81:1390\u20131397.52","journal-title":"Transplantation"},{"key":"8347_CR52","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","volume":"371","author":"K Blanc Le","year":"2008","unstructured":"Le Blanc K, Frassoni F, Ball L et al (2008) Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 371:1579\u20131586","journal-title":"Lancet"},{"key":"8347_CR53","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/09553009014550431","volume":"57","author":"CS Potten","year":"1990","unstructured":"Potten CS, Owen G, Roberts SA (1990) The temporal and spatial changes in cell proliferation within the irradiated crypts of the murine small intestine. Int J Radiat Biol 57:185\u2013199","journal-title":"Int J Radiat Biol"},{"key":"8347_CR54","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1667\/RR3302","volume":"163","author":"MH Gaugler","year":"2005","unstructured":"Gaugler MH, Vereycken-Holler V, Squiban C, Vandamme M, Vozenin-Brotons MC, Benderitter M (2005) Pravastatin limits endothelial activation after irradiation and decreases the resulting inflammatory and thrombotic responses. Radiat Res 163:479\u2013487","journal-title":"Radiat Res"},{"key":"8347_CR55","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.2353\/ajpath.2006.060116","volume":"169","author":"F Milliat","year":"2006","unstructured":"Milliat F, Francois A, Isoir M et al (2006) Influence of endothelial cells on vascular smooth muscle cells phenotype after irradiation: implication in radiation-induced vascular damages. Am J Pathol 169:1484\u20131495","journal-title":"Am J Pathol"},{"key":"8347_CR56","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1126\/science.1060191","volume":"293","author":"F Paris","year":"2001","unstructured":"Paris F, Fuks Z, Kang A et al (2001) Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 293:293\u2013297","journal-title":"Science"},{"key":"8347_CR57","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s11373-008-9256-9","volume":"15","author":"J Zhang","year":"2008","unstructured":"Zhang J, Gong JF, Zhang W, Zhu WM, Li JS (2008) Effects of transplanted bone marrow mesenchymal stem cells on the irradiated intestine of mice. J Biomed Sci 15:585\u2013594","journal-title":"J Biomed Sci"},{"key":"8347_CR58","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-0-387-34133-0_2","volume":"585","author":"A Semont","year":"2006","unstructured":"Semont A, Francois S, Mouiseddine M et al (2006) Mesenchymal stem cells increase self-renewal of small intestinal epithelium and accelerate structural recovery after radiation injury. Adv Exp Med Biol 585:19\u201330","journal-title":"Adv Exp Med Biol"},{"key":"8347_CR59","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1269\/jrr.09091","volume":"51","author":"K Kudo","year":"2010","unstructured":"Kudo K, Liu Y, Takahashi K et al (2010) Transplantation of mesenchymal stem cells to prevent radiation-induced intestinal injury in mice. J Radiat Res 51:73\u201379","journal-title":"J Radiat Res"},{"key":"8347_CR60","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/14653249.2011.616194","volume":"14","author":"Z Gao","year":"2012","unstructured":"Gao Z, Zhang Q, Han Y, Cheng X, Lu Y, Fan L, Wu Z (2012) Mesenchymal stromal cell-conditioned medium prevents radiation-induced small intestine injury in mice. Cytotherapy 14:267\u2013273","journal-title":"Cytotherapy"},{"key":"8347_CR61","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/cdd.2009.187","volume":"17","author":"A Semont","year":"2010","unstructured":"Semont A, Mouiseddine M, Francois A et al (2010) Mesenchymal stem cells improve small intestinal integrity through regulation of endogenous epithelial cell homeostasis. Cell Death Differ 17:952\u2013961","journal-title":"Cell Death Differ"},{"key":"8347_CR62","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s10350-007-9153-8","volume":"51","author":"B Lorenzi","year":"2008","unstructured":"Lorenzi B, Pessina F, Lorenzoni P et al (2008) Treatment of experimental injury of anal sphincters with primary surgical repair and injection of bone marrow-derived mesenchymal stem cells. Dis Colon Rectum 51:411\u2013420","journal-title":"Dis Colon Rectum"},{"key":"8347_CR63","doi-asserted-by":"crossref","first-page":"e24072","DOI":"10.1371\/journal.pone.0024072","volume":"6","author":"S Saha","year":"2011","unstructured":"Saha S, Bhanja P, Kabarriti R, Liu L, Alfieri AA, Guha C (2011) Bone marrow stromal cell transplantation mitigates radiation-induced gastrointestinal syndrome in mice. PLoS One 6:e24072","journal-title":"PLoS One"},{"key":"8347_CR64","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.canrad.2007.09.004","volume":"11","author":"D Peiffert","year":"2007","unstructured":"Peiffert D, Simon JM, Eschwege F (2007) Epinal radiotherapy accident: passed, present, future. Cancer Radiother 11:309\u2013312","journal-title":"Cancer Radiother"},{"key":"8347_CR65","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.canrad.2009.05.011","volume":"13","author":"V Marchesi","year":"2009","unstructured":"Marchesi V, Aigle D, Peiffert D, Noel A, Simon JM (2009) Securitization of the bi-site radiotherapy activity as part of the resumption of treatments in the Hospital of Epinal by the team of Alexis Vautrin Nancy Cancer Center. Cancer Radiother 13:740\u2013743","journal-title":"Cancer Radiother"},{"key":"8347_CR66","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/art.33313","volume":"64","author":"EW Choi","year":"2012","unstructured":"Choi EW, Shin IS, Park SY et al (2012) Reversal of serologic, immunologic, and histologic dysfunction in mice with systemic lupus erythematosus by long-term serial adipose tissue-derived mesenchymal stem cell transplantation. Arthritis Rheum 64:243\u2013253","journal-title":"Arthritis Rheum"},{"key":"8347_CR67","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1097\/00007632-200012150-00009","volume":"25","author":"M Korff Von","year":"2000","unstructured":"Von Korff M, Jensen MP, Karoly P (2000) Assessing global pain severity by self-report in clinical and health services research. Spine 25:3140\u20133151, Phila Pa 1976","journal-title":"Spine"},{"key":"8347_CR68","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jpain.2003.12.005","volume":"5","author":"G Tan","year":"2004","unstructured":"Tan G, Jensen MP, Thornby JI, Shanti BF (2004) Validation of the Brief Pain Inventory for chronic nonmalignant pain. J Pain 5:133\u2013137","journal-title":"J Pain"},{"key":"8347_CR69","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361\u2013370","journal-title":"Acta Psychiatr Scand"},{"key":"8347_CR70","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr","year":"1992","unstructured":"Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473\u2013483","journal-title":"Med Care"},{"key":"8347_CR71","first-page":"173","volume":"18","author":"L Sensebe","year":"2008","unstructured":"Sensebe L, Bourin P (2008) Producing MSC according GMP: process and controls. Biomed Mater Eng 18:173\u2013177","journal-title":"Biomed Mater Eng"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-012-8347-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-012-8347-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-012-8347-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T01:38:15Z","timestamp":1562549895000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-012-8347-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,8]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["8347"],"URL":"https:\/\/doi.org\/10.1007\/s12016-012-8347-6","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,8]]}}}